Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Comparative Study of the Efficacy of Acupuncture Versus Conventional Treatment for the Management of Chronic Pain in Patients With Chronic Kidney Disease Receiving Conservative Treatment or Renal Replacement Therapy (Peritoneal Dialysis or Hemodialysis)

NCT07891819 is registered in ClinicalTrials.gov with Federal University of São Paulo as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07891819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Comparative Study of the Efficacy of Acupuncture Versus Conventional Treatment for the Management of Chronic Pain in Patients With Chronic Kidney Disease Receiving Conservative Treatment or Renal Replacement Therapy (Peritoneal Dialysis or Hemodialysis)
Lead sponsor
Federal University of São Paulo
Phase
Not applicable
Overall status
Completed
Start date
September 6, 2023
Completion date
February 17, 2026
Enrollment
110 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pain, neuralgia, renal insufficiency,chronic

Arms

As registered; 2 arms.

  • Acupuncture plus conventional treatment - Experimental ExperimentalAcupuncture, Optimized conventional pharmacological treatment

    Individualized acupuncture administered weekly for approximately four months, with 16 sessions planned and a minimum of 10 sessions considered necessary for efficacy evaluation. Participants also received optimized conventional pharmacological treatment.

  • Conventional treatment alone Active comparatorOptimized conventional pharmacological treatment

    Optimized conventional pharmacological treatment for chronic pain, without acupuncture.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Change in pain intensity from baseline to the final study visit Baseline and 5 months

    Change in pain intensity from baseline to 5 months, measured using the 0-to-10 Visual Analog Scale (VAS) for pain, where 0 indicates no pain and 10 the worst imaginable pain. Higher scores indicate worse pain; a negative change indicates improvement.

Lead sponsor's other trials

Federal University of São Paulo, most recent start first.

Similar trials

Same condition (Neuralgia) and phase, most recent start first.